Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Nasopharyngeal Carcinoma 5Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Lymphoma 1Immunotherapy Esophagus Cancer 1Hypopharyngeal Neoplasms 1Hepatic Artery Infusion 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 14Specimen Handling 6Cetuximab 6Surgical Procedures, Operative 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 51,2-diaminocyclohexaneplatinum II citrate 5toripalimab 4Radiotherapy 4Platinum 4Docetaxel 4Celecoxib 4pembrolizumab 3X-Rays 3130-nm albumin-bound paclitaxel 3camrelizumab 2Radiotherapy, Image-Guided 2Radiation 2Paclitaxel 2Fluorouracil 2Chemoradiotherapy 2Carboplatin 2Biopsy 2tislelizumab 1sodium thiosulfate 1sacituzumab govitecan 1nimotuzumab 1nedaplatin 1merphos 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hypopharyngeal Neoplasms × nedaplatin × Clear all
NCT05860335 2024-02-20

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Head & Neck

Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡